Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07160946

Risk Assessment for HBV-Related Liver Cancer

Research on Risk Assessment and Intervention of HBV-Related Liver Cancer Based on Multimodal Data Fusion

Status
Recruiting
Phase
Study type
Observational
Enrollment
6,000 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Liver cancer is a severe disease worldwide. The incidence and mortality rates of liver cancer in China is the highest in the world. This project aims to perform a prospective, multi-center, large sample cohort study for HBV related high-risk individuals. Based on multimodal data fusion and AI technique, stratified management and follow-up system are conducted for HBV-related high-risk populations of liver cancer, in order to improve the early diagnosis rate of liver cancer.

Conditions

Interventions

TypeNameDescription
OTHERAI folow-up systemIn AI follow-up group, patients will be followed up by an AI system.

Timeline

Start date
2025-05-10
Primary completion
2032-12-30
Completion
2032-12-30
First posted
2025-09-08
Last updated
2025-09-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07160946. Inclusion in this directory is not an endorsement.